blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1889609

EP1889609 - Immune response modifier foam formulations [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.03.2020
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  19.04.2019
FormerGrant of patent is intended
Status updated on  03.01.2019
FormerExamination is in progress
Status updated on  15.02.2017
Most recent event   Tooltip23.07.2021Lapse of the patent in a contracting state
New state(s): MT		published on 25.08.2021  [2021/34]
Applicant(s)For all designated states
Meda AB
Pipersväg 2 A / Box 906
170 09 Solna / SE
[2019/04]
Former [2008/08]For all designated states
Meda AB
Pipers väg 2 A/Box 906
17009 Solna / SE
Inventor(s)01 / Vallejo, Janet A.
4100 Camberwell Drive North
Eagan, MN 55123 / US
 [2008/08]
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2019/21]FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Former [2008/08]Endler, Gabriele
MEDA Pharma GmbH & Co. KG Patents & Trademarks Benzstraße 1
61352 Bad Homburg / DE
Application number, filing date07013703.912.07.2007
[2008/08]
Priority number, dateUS20060807669P18.07.2006         Original published format: US 807669 P
[2008/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1889609
Date:20.02.2008
Language:EN
[2008/08]
Type: A3 Search report 
No.:EP1889609
Date:13.08.2008
[2008/33]
Type: B1 Patent specification 
No.:EP1889609
Date:22.05.2019
Language:EN
[2019/21]
Search report(s)(Supplementary) European search report - dispatched on:EP16.07.2008
ClassificationIPC:A61K9/12, A61K31/437, A61K31/4745, A61P15/00, A61P15/02, A61P17/00, A61P17/08, A61P17/12, A61P17/16, A61P17/18, A61P31/12, A61P35/00, A61P43/00
[2008/08]
CPC:
A61K9/12 (EP,NO,US); A61K31/4745 (EP,NO,US); A61K31/437 (EP,US);
A61K9/0014 (EP,US); A61P11/06 (EP); A61P15/00 (EP);
A61P15/02 (EP); A61P17/00 (EP,NO); A61P17/02 (EP);
A61P17/08 (EP); A61P17/12 (EP); A61P17/14 (EP);
A61P17/16 (EP); A61P17/18 (EP); A61P25/00 (EP);
A61P27/16 (EP); A61P31/12 (EP); A61P31/20 (EP);
A61P31/22 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP,NO); A61P37/00 (EP); A61P37/02 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/04 (EP);
Y02A50/30 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/21]
Former [2008/08]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL13.02.2009
BA13.02.2009
HR13.02.2009
MK13.02.2009
RS13.02.2009
TitleGerman:Schaumformulierungen zur Modifikation der Immunantwort[2008/08]
English:Immune response modifier foam formulations[2008/08]
French:Formulations de mousse modifiant la réponse immunitaire[2008/08]
Examination procedure13.02.2009Examination requested  [2009/13]
11.03.2009Despatch of a communication from the examining division (Time limit: M06)
27.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
11.12.2009Reply to a communication from the examining division
12.05.2011Despatch of a communication from the examining division (Time limit: M06)
01.11.2011Reply to a communication from the examining division
21.11.2014Despatch of a communication from the examining division (Time limit: M04)
17.03.2015Reply to a communication from the examining division
23.09.2016Despatch of a communication from the examining division (Time limit: M02)
17.10.2016Reply to a communication from the examining division
03.02.2017Despatch of a communication from the examining division (Time limit: M04)
24.04.2017Reply to a communication from the examining division
09.03.2018Despatch of a communication from the examining division (Time limit: M04)
19.07.2018Reply to a communication from the examining division
04.01.2019Communication of intention to grant the patent
11.04.2019Fee for grant paid
11.04.2019Fee for publishing/printing paid
11.04.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.03.2009
Opposition(s)25.02.2020No opposition filed within time limit [2020/18]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
11.12.2009Request for further processing filed
11.12.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
31.07.2009Renewal fee patent year 03
02.08.2010Renewal fee patent year 04
01.08.2011Renewal fee patent year 05
31.07.2012Renewal fee patent year 06
31.07.2013Renewal fee patent year 07
31.07.2014Renewal fee patent year 08
31.07.2015Renewal fee patent year 09
01.08.2016Renewal fee patent year 10
12.07.2017Renewal fee patent year 11
23.07.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.07.2007
AT22.05.2019
CY22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
MT22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
IE12.07.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
PT22.09.2019
[2021/34]
Former [2021/32]HU12.07.2007
AT22.05.2019
CY22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
IE12.07.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
PT22.09.2019
Former [2021/31]AT22.05.2019
CY22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
IE12.07.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
IS22.09.2019
PT22.09.2019
Former [2021/26]AT22.05.2019
CY22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
IE12.07.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/36]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
IE12.07.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/25]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
PL22.05.2019
RO22.05.2019
SE22.05.2019
SI22.05.2019
SK22.05.2019
TR22.05.2019
LU12.07.2019
BE31.07.2019
CH31.07.2019
LI31.07.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/17]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
RO22.05.2019
SE22.05.2019
SK22.05.2019
TR22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/14]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
MC22.05.2019
NL22.05.2019
RO22.05.2019
SE22.05.2019
SK22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/12]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
IT22.05.2019
LT22.05.2019
LV22.05.2019
NL22.05.2019
RO22.05.2019
SE22.05.2019
SK22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/11]AT22.05.2019
CZ22.05.2019
DK22.05.2019
EE22.05.2019
ES22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
NL22.05.2019
RO22.05.2019
SE22.05.2019
SK22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/10]AT22.05.2019
CZ22.05.2019
DK22.05.2019
ES22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
NL22.05.2019
RO22.05.2019
SE22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2020/09]CZ22.05.2019
DK22.05.2019
ES22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
NL22.05.2019
SE22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2019/51]ES22.05.2019
FI22.05.2019
LT22.05.2019
LV22.05.2019
NL22.05.2019
SE22.05.2019
BG22.08.2019
GR23.08.2019
PT22.09.2019
Former [2019/49]ES22.05.2019
FI22.05.2019
LT22.05.2019
NL22.05.2019
SE22.05.2019
PT22.09.2019
Former [2019/48]ES22.05.2019
FI22.05.2019
LT22.05.2019
SE22.05.2019
PT22.09.2019
Former [2019/47]ES22.05.2019
FI22.05.2019
LT22.05.2019
Documents cited:Search[XY] WO2005020995  (3M INNOVATIVE PROPERTIES CO et al.) [X] 1-29 * page 13, lines 6-32 * * page 14, line 6 - page 16, line 16 * * page 16, lines 9-13 * * claims 3,4,6 *[Y] 30-43
 [X] US2005175630  (RAZ EYAL et al.) [X] 1-33 * page 13, column L, paragraph 155 * * page 21, column L, paragraphs 284,285 * * page 22, column L, paragraph 299 *
 [Y] US2005201959  (DAVID NATHANIEL E et al.) [Y] 30-43 * page 1, column R, paragraph 9 * * page 3, lines 29-40 * * page 5, column R, paragraph 56 *
 [Y] US2003026794  (FEIN HOWARD et al.) [Y] 33-43 * page 3, column R, paragraphs 26,27 *
 [A] EP1512685  (MINNESOTA MINING & MFG et al.) [A] 1-43 * example 9 * * abstract *
 [A]   HENGGE U ET AL: "Topical immunomodulators-progress towards treating inflammation, infection, and cancer", LANCET INFECTIOUS DISEASES, XX, US, vol. 1, no. 3, 1 October 2001 (2001-10-01), pages 189 - 198, XP004812198, ISSN: 1473-3099 [A] 1-43 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1473-3099(01)00095-0
ExaminationWO03080114
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.